DETX
Liberty Defense Holdings, Ltd. Common Shares (DETX) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
Negative interest coverage and modest net leverage imply refinancing sensitivity if rates stay elevated, but peers with heavier balance sheets face greater near-term pressure.
Very high days of inventory outstanding can trap working capital and pressure margins if demand normalizes slowly, though this appears less severe than peers with tighter liquidity.
Days of sales outstanding remain elevated, increasing cash-collection risk and limiting flexibility versus faster-turning peers in the same distribution-heavy model.
A long cash conversion cycle can delay cash realization and constrain reinvestment capacity, but the strong current and quick ratios provide a better buffer than weaker peers.
Opportunities
Strong current and quick ratios support operating flexibility and supplier confidence, giving DETX more resilience than leveraged peers when demand or pricing weakens.
Low debt-to-equity and modest net debt-to-EBITDA reduce balance-sheet drag, leaving more room to absorb cyclical volatility than more indebted competitors.
High payables days can preserve cash and partially fund growth, creating a working-capital advantage versus peers that must pay suppliers faster.
If inventory and receivables normalize, cash release could improve liquidity and free capacity for growth, with greater upside than peers already operating near efficient levels.
Overall Score
DETX shows a mixed forward profile: liquidity and modest leverage support resilience versus peers, but weak coverage and working-capital intensity keep risks and upside moderate.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Liberty Defense Holdings, Ltd. Common Shares. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
